These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1323679)

  • 1. Substituted 1-(aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinolines: a novel class of very potent antinociceptive agents with varying degrees of selectivity for kappa and mu opioid receptors.
    Vecchietti V; Clarke GD; Colle R; Dondio G; Giardina G; Petrone G; Sbacchi M
    J Med Chem; 1992 Aug; 35(16):2970-8. PubMed ID: 1323679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (1S)-1-(aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinoline and heterocycle-condensed tetrahydropyridine derivatives: members of a novel class of very potent kappa opioid analgesics.
    Vecchietti V; Clarke GD; Colle R; Giardina G; Petrone G; Sbacchi M
    J Med Chem; 1991 Aug; 34(8):2624-33. PubMed ID: 1652025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (2S)-1-(arylacetyl)-2-(aminomethyl)piperidine derivatives: novel, highly selective kappa opioid analgesics.
    Vecchietti V; Giordani A; Giardina G; Colle R; Clarke GD
    J Med Chem; 1991 Jan; 34(1):397-403. PubMed ID: 1846921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potency.
    Spetea M; Greiner E; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2005 Jul; 48(15):5052-5. PubMed ID: 16033285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity.
    Froimowitz M; Pick CG; Pasternak GW
    J Med Chem; 1992 May; 35(9):1521-5. PubMed ID: 1315868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiospecificity of kappa receptors: comparison of racemic compounds and active enantiomers in two novel series of kappa agonist analgesics.
    Colle R; Clarke GD; Dondio G; Giardina G; Petrone G; Sbacchi M; Vecchietti V
    Chirality; 1992; 4(1):8-15. PubMed ID: 1322687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antinociceptive activity, and opioid receptor profiles of substituted trans-3-(decahydro- and octahydro-4a-isoquinolinyl)phenols.
    Judd DB; Brown DS; Lloyd JE; McElroy AB; Scopes DI; Birch PJ; Hayes AG; Sheehan MJ
    J Med Chem; 1992 Jan; 35(1):48-56. PubMed ID: 1310115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective kappa-opioid analgesics. 2. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide derivatives.
    Halfpenny PR; Hill RG; Horwell DC; Hughes J; Hunter JC; Johnson S; Rees DC
    J Med Chem; 1989 Jul; 32(7):1620-6. PubMed ID: 2567782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines.
    Hsin LW; Chang LT; Rothman RB; Dersch CM; Fishback JA; Matsumoto RR
    J Med Chem; 2010 Feb; 53(3):1392-6. PubMed ID: 20055417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
    Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
    J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of mu- and kappa-receptors by means of correlation of analgesic potency in vivo and receptor binding affinity in vitro of various opioid agonists.
    Ensinger HA; Stockhaus K; Merz H
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):649-53. PubMed ID: 6096651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CI-977, a novel and selective agonist for the kappa-opioid receptor.
    Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
    Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly selective kappa opioid analgesics. 4. Synthesis of some conformationally restricted naphthalene derivatives with high receptor affinity and selectivity.
    Halfpenny PR; Horwell DC; Hughes J; Humblet C; Hunter JC; Neuhaus D; Rees DC
    J Med Chem; 1991 Jan; 34(1):190-4. PubMed ID: 1846919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors.
    McLaughlin JP; Nowak D; Sebastian A; Schultz AG; Archer S; Bidlack JM
    Eur J Pharmacol; 1995 Dec; 294(1):201-6. PubMed ID: 8788432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
    Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives.
    Clark CR; Halfpenny PR; Hill RG; Horwell DC; Hughes J; Jarvis TC; Rees DC; Schofield D
    J Med Chem; 1988 Apr; 31(4):831-6. PubMed ID: 2832603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
    J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.